logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Blood transfusion as a risk factor for non-Hodgkin lymphoma.

    Article - En anglais

    In a case control study of 280 out of 426 consecutive patients with a recent diagnosis of non-Hodgkin lymphoma (NHL) and 1827 control subjects, 53 (19%) and 230 (13%) respectively had received blood transfusions 1 year or more before the interview.

    Using an age-and sex-stratified analysis the odds ratio (OR) for transfusion was 1.74 (95% CI 1.24-2.44).

    ORs were also determined for transfusions received in the intervals 1-5,6.15,16-25 and =26 years before diagnosis.

    In the interval 6-15 years, the OR for transfusion was 2.83 (95% CI 1.60 4.99) whereas ORs for transfusions received in other intervals were lower and not significantly elevated.

    Histological diagnoses (Kiel classification) and results of staging procedures were known for 185 patients.

    For low-grade NHL of nodal B-cell chronic lymphocytic leukaemia (B-CLL) or immunocytoma type, the OR for transfusions was 4.15 (95% Cl 1.92-9.01).

    For low-grade nodal lymphomas of follicle centre cell type and high-grade nodal lymphomas, no relation to transfusions could be demonstrated.

    For high-grade extranodal lymphoma as sole manifestation, OR for transfusions was 3.27 (95%, CI 1.30 8.24).

    It is concluded that blood transfusion may be a risk factor for NHLs especially those of B-CLL or immunocytoma type and for high-grade extranodal lymphoma.

    Mots-clés Pascal : Lymphome non hodgkinien, Facteur risque, Transfusion, Sang, Epidémiologie, Suède, Europe, Homme, Hémopathie maligne, Lymphoprolifératif syndrome, Etude cas témoin

    Mots-clés Pascal anglais : Non Hodgkin lymphoma, Risk factor, Transfusion, Blood, Epidemiology, Sweden, Europe, Human, Malignant hemopathy, Lymphoproliferative syndrome, Case control study

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0245589

    Code Inist : 002B19B. Création : 199608.